JANX (Janux Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Janux Therapeutics, Inc. Common Stock (JANX) is a publicly traded Healthcare sector company. As of May 21, 2026, JANX trades at $14.15 with a market cap of $855.61M and a P/E ratio of -7.74. JANX moved +4.24% today. Year to date, JANX is +4.73%; over the trailing twelve months it is -43.31%. Its 52-week range spans $12.12 to $71.71. Analyst consensus is strong buy with an average price target of $39.79. Rallies surfaces JANX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading JANX stock inside the company?

Recent JANX insider activity includes Dobek Maria sold 2.04K, Meyer Andrew Hollman sold 1.88K, DiRaimondo Thomas sold 2.50K, Campbell David Alan sold 8.07K, and Winter Charles M. sold 2.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

JANX Key Metrics

Key financial metrics for JANX
MetricValue
Price$14.15
Market Cap$855.61M
P/E Ratio-7.74
EPS$-1.84
Dividend Yield0.00%
52-Week High$71.71
52-Week Low$12.12
Volume931.95K
Avg Volume0
Revenue (TTM)$13.73M
Net Income$-114.48M
Gross Margin0.00%

Recent JANX Insider Trades

  • Dobek Maria sold 2.04K (~$28.88K) on May 11, 2026.
  • Meyer Andrew Hollman sold 1.88K (~$25.80K) on Jan 2, 2026.
  • DiRaimondo Thomas sold 2.50K (~$34.39K) on Jan 2, 2026.
  • Campbell David Alan sold 8.07K (~$110.83K) on Jan 2, 2026.
  • Winter Charles M. sold 2.40K (~$32.97K) on Jan 2, 2026.

JANX Analyst Consensus

15 analysts cover JANX: 0 strong buy, 13 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.79.

Common questions about JANX

Who is trading JANX stock inside the company?
Recent JANX insider activity includes Dobek Maria sold 2.04K, Meyer Andrew Hollman sold 1.88K, DiRaimondo Thomas sold 2.50K, Campbell David Alan sold 8.07K, and Winter Charles M. sold 2.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for JANX?
Yes. Rallies tracks JANX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is JANX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JANX. It does not provide personalized investment advice.
JANX

JANX